🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521863-11-00
Ongoing Phase I

A Phase 1 study of a novel sublingual insulin formulation

2025-521863-11-00 · tracked via the Priya Life Science EU tracker
Sponsor
Sublin B.V.
Sponsor type
Pharmaceutical company
Therapeutic area
Metabolism
Decision date
04/09/2026
Enrollment target
19
Sites
Netherlands

Condition studied

Type 1 diabetes mellitus

Eligibility

Age group
18-64 years
Sex
Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521863-11-00 on CTIS ↗ ← All trials in the EU